Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (250)	7/27/2004 4:30:00 PM
From: tuck	Read Replies (2) of 946

Thanks, Erik, your comments on the Stellar trials are helpful. I favor the treatment effect for the promising MST, as enrollment for this large a number of patients might be hard to skew that wildly in your compound's favor without making the enrollment process very slow. Maybe I'm naive about that. Having missed the good window, I wonder if CTIC can't wait until there's some actual excitement about those results or pixantrone's some months down the road. That would drive share price and investor interest higher, and make for more proceeds, IMO. I would kind of like to see this secondary postponed. Your thoughts? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next